HGB-212: A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects with Transfusion-dependent ?-Thalassemia, who have a B0/B0 Genotype, by Transplantation of Autologous CD34+ Stem Cells Transduce

Project: Research project

Project Details

StatusActive
Effective start/end date5/26/178/31/50

Funding

  • bluebird bio, Inc.
  • bluebird bio, Inc.